NCT00690612 - Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Hypertension

Interventions

DRUG

candesartan cilexetil

0.05, 0.2, 0.4 mg/kg, oral solution, single daily dose

Trial Locations (13)

Research Site, Edegem

Research Site, Ghent

Research Site, Strasbourg

Research Site, Erlangen

Research Site, Heidelberg

Research Site, Marburg

Research Site, Rostock

Research Site, Genova

Research Site, Padua

Research Site, Gda�sk

Research Site, Krakow

Research Site, Crimea

Research Site, Kyiv